These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 34396820)

  • 21. The mystery of the occluded port that allowed blood withdrawal: is it safe to use standard needles to access ports? A case report and literature review.
    Cataldo R; Costa F; Vitiello M; Brescia F; Proscia P; Falco C; Carassiti M
    J Surg Oncol; 2014 Apr; 109(5):500-3. PubMed ID: 24310214
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Transesophageal echocardiography-guided implantation of totally implantable venous access devices via the internal jugular vein: retrospective analysis of 297 cases in pediatric patients.
    Chen Y; Xing D; Wu L; Lin H; Lin T; Ding F; Xu L
    World J Surg Oncol; 2022 Aug; 20(1):272. PubMed ID: 36042478
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Management of functional complications of totally implantable venous access devices by an advanced practice nursing team: 5 years of clinical experience.
    Goossens GA; Stas M; Moons P
    Eur J Oncol Nurs; 2012 Dec; 16(5):465-71. PubMed ID: 22265937
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Feasibility and safety of endovascular stripping of totally implantable venous access devices.
    Heye S; Maleux G; Goossens GA; Vaninbroukx J; Jerôme M; Stas M
    Cardiovasc Intervent Radiol; 2012 Jun; 35(3):607-12. PubMed ID: 21479744
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The role of antibiotics in preventing totally implantable venous access device (TIVAD) infections; is there a population that would benefit?
    Jo JE; Tang EY; Pua BB
    Clin Imaging; 2018; 51():213-216. PubMed ID: 29864730
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Complications and Management of Totally Implantable Central Venous Access Ports in Cancer Patients at a University Hospital in Oman.
    D'Souza PC; Kumar S; Kakaria A; Al-Sukaiti R; Al-Baimani K; Hamid RS; Mittal AK; Al-Balushi M; Burney IA; Al-Moundhri MS
    Sultan Qaboos Univ Med J; 2021 Feb; 21(1):e103-e109. PubMed ID: 33777430
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Implantable venous access devices in children with severe hemophilia: a tertiary pediatric institutional experience.
    Bedoya MA; Raffini L; Durand R; Acord MR; Srinivasan A; Krishnamurthy G; Vatsky S; Escobar F; Cahill AM
    Pediatr Radiol; 2020 Jul; 50(8):1148-1155. PubMed ID: 32390060
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Case report: Extravascular catheter migration in a child: A rare complication of the totally implantable venous access device.
    Lu X; Ren Y; Wan H; Xu Q; Duan S
    Medicine (Baltimore); 2023 Feb; 102(8):e32710. PubMed ID: 36827053
    [TBL] [Abstract][Full Text] [Related]  

  • 29. PICC-PORT totally implantable vascular access device in breast cancer patients undergoing chemotherapy.
    Bertoglio S; Cafiero F; Meszaros P; Varaldo E; Blondeaux E; Molinelli C; Minuto M
    J Vasc Access; 2020 Jul; 21(4):460-466. PubMed ID: 31674857
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Update on totally implantable venous access devices.
    Zaghal A; Khalife M; Mukherji D; El Majzoub N; Shamseddine A; Hoballah J; Marangoni G; Faraj W
    Surg Oncol; 2012 Sep; 21(3):207-15. PubMed ID: 22425356
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Implanting totally implantable venous access ports in the upper arm is feasible and safe for patients with early breast cancer.
    Xu H; Chen R; Jiang C; You S; Zhu Q; Li Y; Li S; Zha X; Wang J
    J Vasc Access; 2020 Sep; 21(5):609-614. PubMed ID: 31841061
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Infection assessment of totally implanted long-term venous access devices.
    Brouns F; Schuermans A; Verhaegen J; De Wever I; Stas M
    J Vasc Access; 2006; 7(1):24-8. PubMed ID: 16596525
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Totally implantable venous access devices in children with cystic fibrosis: incidence and type of complications.
    Deerojanawong J; Sawyer SM; Fink AM; Stokes KB; Robertson CF
    Thorax; 1998 Apr; 53(4):285-9. PubMed ID: 9741372
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Complications with totally implantable venous access device. A retrospective of 116 cases].
    Talfer S; Conessa C; Hervé S; Roguet E; de Rotalier P; Poncet JL
    Presse Med; 2003 Aug; 32(27):1263-8. PubMed ID: 14506448
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The catheter is stuck: complications experienced during removal of a totally implantable venous access device. A single-center study in 200 children.
    Wilson GJ; van Noesel MM; Hop WC; van de Ven C
    J Pediatr Surg; 2006 Oct; 41(10):1694-8. PubMed ID: 17011271
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prolong the flushing and locking interval of TIVAD is feasible in COVID-19: An overview of systematic reviews.
    Wang Y; Zhao J; Wan GM
    J Vasc Access; 2023 Nov; 24(6):1253-1259. PubMed ID: 35430915
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Detachment and embolization of totally implantable central venous access devices: diagnosis and management.
    Kara H; Arikan AE; Dulgeroglu O; Uras C; Icten GE; Tutar B; Parlakkilic UT; Sonmez O
    Acta Chir Belg; 2022 Aug; 122(4):240-247. PubMed ID: 33645456
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Randomized Clinical Trial Evaluating Complications and Complication-Related Removal of Arm-Situated Power-Injectable and Non-Power-Injectable Totally Implanted Venous Access Devices among Cancer Patients.
    Burbridge B; Plewes C; Stoneham G; Szkup P; Otani R; Babyn P; Bryce R
    J Vasc Interv Radiol; 2018 May; 29(5):648-656.e3. PubMed ID: 29499999
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Long-term, totally implantable central venous access ports connected to a Groshong catheter for chemotherapy of solid tumours: experience from 178 cases using a single type of device.
    Biffi R; Corrado F; de Braud F; de Lucia F; Scarpa D; Testori A; Orsi F; Bellomi M; Mauri S; Aapro M; Andreoni B
    Eur J Cancer; 1997 Jul; 33(8):1190-4. PubMed ID: 9301441
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Incidence and Risk Factors for Totally Implantable Venous Access Device Infections in Pediatric Patients With Cancer: A Study of 25,954 Device-Days.
    Lee JK; Choi YB
    J Korean Med Sci; 2022 Sep; 37(35):e266. PubMed ID: 36065650
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.